Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SLDB | US
-0.10
-1.11%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
30/08/2024
8.93
9.04
9.04
8.43
Solid Biosciences Inc. a life science company engages in developing therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003 a next-generation gene transfer candidate for the treatment of Duchenne muscular dystrophy (Duchenne); AVB-202-TT a gene therapy program for the treatment of Friedreich's ataxia; AVB-401 a gene therapy program for the treatment of BAG3-mediated dilated cardiomyopathy; and other drugs for the treatment of undisclosed cardiac diseases. It also engages in developing platform technologies including dual gene expression a technology for packaging multiple transgenes into one vector as well as novel capsids. The company has collaboration and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize new gene therapies for Duchenne. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Charlestown Massachusetts.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Price Below SMA10D
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
58.7%1 month
85.3%3 months
100.0%6 months
87.3%-
-
1.78
0.13
0.11
-3.69
1.16
-
-97.67M
344.66M
344.66M
-
-
-
-100.00
-50.81
5.14
9.25
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
1.96
Range1M
3.75
Range3M
5.16
Rel. volume
0.61
Price X volume
1.34M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Cipher Pharmaceuticals Inc | CPHRF | Drug Manufacturers-Specialty & Generic | 14.05 | 359.52M | 0.79% | 15.64 | 0.00% |
Aurora Cannabis Inc | ACB | Drug Manufacturers-Specialty & Generic | 6.08 | 332.34M | 1.16% | n/a | 0.00% |
Elite Pharmaceuticals Inc | ELTP | Drug Manufacturers-Specialty & Generic | 0.2779 | 296.87M | -2.66% | 14.00 | 0.00% |
Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 1.93 | 292.72M | 0.00% | n/a | -471.04% |
Alpha Teknova Inc. Common Stock | TKNO | Drug Manufacturers-Specialty & Generic | 4.94 | 263.32M | 5.11% | n/a | 39.24% |
ESSA Pharma Inc | EPIX | Drug Manufacturers-Specialty & Generic | 5.59 | 248.02M | 1.82% | n/a | 0.27% |
Procaps Group S.A. Ordinary Shares | PROC | Drug Manufacturers-Specialty & Generic | 1.97 | 217.91M | 0.00% | 3.86 | 0.00% |
Galectin Therapeutics Inc | GALT | Drug Manufacturers-Specialty & Generic | 2.695 | 167.84M | -1.64% | n/a | -113.78% |
OptiNose Inc | OPTN | Drug Manufacturers-Specialty & Generic | 1.04 | 156.81M | -2.80% | n/a | -294.40% |
CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 1.94 | 135.57M | 3.19% | n/a | 1.07% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Marine Products Corporation | MPX | Recreational Vehicles | 9.4 | 326.35M | 0.00% | 12.70 | 0.00% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 28.64 | 316.93M | -0.52% | 18.84 | -621.78% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 18.53 | 314.66M | -0.70% | 36.33 | 26.79% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 15.53 | 251.70M | 1.70% | 9.96 | 15.44% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 53.7 | 152.52M | -0.37% | 8.42 | 71.47% |
Unifi Inc | UFI | Textile Manufacturing | 6.83 | 124.66M | -2.84% | n/a | 52.56% |
Culp Inc | CULP | Textile Manufacturing | 5.02 | 62.60M | 0.20% | n/a | 5.89% |
REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 3.68 | 39.85M | -1.12% | n/a | 54.96% |
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 2.34 | 28.51M | 13.04% | n/a | 16.03% |
ILAG | ILAG | Building Products & Equipment | 1.25 | 22.57M | 6.84% | n/a | 5.48% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -3.69 | - | Cheaper |
Ent. to Revenue | 1.16 | - | Cheaper |
PE Ratio | - | 28.45 | - |
Price to Book | 1.78 | 11.25 | Cheaper |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 99.96 | - | Riskier |
Debt to Equity | 0.13 | -0.58 | Expensive |
Debt to Assets | 0.11 | 0.43 | Cheaper |
Market Cap | 344.66M | - | Emerging |